X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs STERLING BIOTECH - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. STERLING BIOTECH WOCKHARDT LTD./
STERLING BIOTECH
 
P/E (TTM) x 16.4 -1.8 - View Chart
P/BV x 1.7 0.1 2,410.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 WOCKHARDT LTD.   STERLING BIOTECH
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
STERLING BIOTECH
Dec-13
WOCKHARDT LTD./
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs2,00011 19,047.6%   
Low Rs7063 20,758.8%   
Sales per share (Unadj.) Rs403.726.8 1,506.0%  
Earnings per share (Unadj.) Rs29.5-15.0 -197.0%  
Cash flow per share (Unadj.) Rs42.4-5.5 -775.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs323.454.9 589.3%  
Shares outstanding (eoy) m110.51267.87 41.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.3 1,292.6%   
Avg P/E ratio x45.9-0.5 -9,880.0%  
P/CF ratio (eoy) x31.9-1.3 -2,509.8%  
Price / Book Value ratio x4.20.1 3,303.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m149,5091,862 8,030.8%   
No. of employees `0007.41.4 544.8%   
Total wages/salary Rs m9,443547 1,727.0%   
Avg. sales/employee Rs Th6,048.65,303.3 114.1%   
Avg. wages/employee Rs Th1,280.2403.8 317.0%   
Avg. net profit/employee Rs Th441.5-2,959.0 -14.9%   
INCOME DATA
Net Sales Rs m44,6147,181 621.3%  
Other income Rs m97043 2,275.8%   
Total revenues Rs m45,5847,223 631.1%   
Gross profit Rs m5,038947 532.1%  
Depreciation Rs m1,4262,543 56.1%   
Interest Rs m1,0124,377 23.1%   
Profit before tax Rs m3,570-5,931 -60.2%   
Minority Interest Rs m-650-   
Prior Period Items Rs m60-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255-1,924 -13.2%   
Profit after tax Rs m3,257-4,007 -81.3%  
Gross profit margin %11.313.2 85.6%  
Effective tax rate %7.132.4 22.0%   
Net profit margin %7.3-55.8 -13.1%  
BALANCE SHEET DATA
Current assets Rs m39,90614,335 278.4%   
Current liabilities Rs m18,42349,809 37.0%   
Net working cap to sales %48.2-494.0 -9.7%  
Current ratio x2.20.3 752.6%  
Inventory Days Days90403 22.4%  
Debtors Days Days98171 57.6%  
Net fixed assets Rs m35,83255,432 64.6%   
Share capital Rs m553268 206.2%   
"Free" reserves Rs m30,37013,935 217.9%   
Net worth Rs m35,73914,701 243.1%   
Long term debt Rs m16,5429,478 174.5%   
Total assets Rs m79,52273,988 107.5%  
Interest coverage x4.5-0.4 -1,275.5%   
Debt to equity ratio x0.50.6 71.8%  
Sales to assets ratio x0.60.1 578.1%   
Return on assets %5.40.5 1,071.7%  
Return on equity %9.1-27.3 -33.4%  
Return on capital %8.7-6.4 -134.7%  
Exports to sales %11.625.9 44.8%   
Imports to sales %4.50.2 2,625.5%   
Exports (fob) Rs m5,1771,860 278.3%   
Imports (cif) Rs m1,99012 16,312.3%   
Fx inflow Rs m7,5891,860 408.0%   
Fx outflow Rs m2,87825 11,564.5%   
Net fx Rs m4,7111,835 256.7%   
CASH FLOW
From Operations Rs m7161,719 41.7%  
From Investments Rs m-8,182-3,148 259.9%  
From Financial Activity Rs m2,5431,426 178.3%  
Net Cashflow Rs m-4,923-3 144,800.0%  

Share Holding

Indian Promoters % 74.5 33.9 219.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.0 -  
FIIs % 7.7 9.9 77.8%  
ADR/GDR % 0.1 16.9 0.6%  
Free float % 15.4 39.3 39.2%  
Shareholders   67,757 21,482 315.4%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   PFIZER  ABBOTT INDIA  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 22, 2017 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS